Resolution Bioscience, a part of Agilent, is pioneering next-generation cancer diagnostics that enable physicians to tailor treatments for each patient using only a blood test — a liquid biopsy.

Biotechnology

Resolution Bioscience

Kevin Lau

Matthew Spaziani

Nellie N.

Ron Newcomb

Jeremy Banks

Kunlun Tan

Mei Huang

Paris Chávez

Arthur Lee

Rushabh Shah

Christopher C.

Gary Painchaud

Frazer Meacham

Brian P.

The Engineering and Development team at Resolution Bioscience is responsible for designing and building innovative software solutions that support the analysis and interpretation of liquid biopsy data. This interdisciplinary group, consisting of software and web developers, DevOps engineers, and quality assurance experts, collaborates to ensure the reliability and efficiency of the diagnostic platforms, ultimately enabling personalized cancer treatment. Their work is crucial for developing the next generation of diagnostic tools that enhance patient outcomes.

Engineering and Development

Quality Assurance and Regulatory Compliance

Engineering and Development

About

Team members

Other teams at Resolution Bioscience

Quality Assurance and Regulatory Compliance